Variation in female reproductive traits such as fertility, fecundity, and fecundability are heritable in humans, but identifying and functionally characterizing genetic variants associated with these traits has been challenging. Here we explore the functional significance and evolutionary history of a C/T polymorphism of SNP rs2071473, which we have previously shown is an eQTL for TAP2 and significantly associated with fecundability (time to pregnancy). We replicated the association between rs2071473 genotype and TAP2 expression using GTEx data and demonstrate that TAP2 is expressed by decidual stromal cells at the maternal-fetal interface.
Introduction
Variation in female reproductive traits, such as age of menarche and menopause, fertility, age at first and last birth, fecundity, and fecundability are heritable in humans [1, 2] .
However, identifying the genetic bases for variation in most of these traits has proven challenging because of limited sample sizes, strong gene-environment interactions [1] [2] [3] , widespread contraceptive use, and significant clinical heterogeneity among infertile couples. For example, while genome-wide association studies (GWAS) have identified loci associated with age of menarche and menopause [4] [5] [6] [7] [8] [9] , and age at first and last birth [10] , few studies have successfully identified genetic variants associated with fertility, fecundity, and fecundability [3, [10] [11] [12] .
We recently performed an integrated expression quantitative trait locus (eQTL) mapping and association study to identify eQTLs in mid-secretory endometrium that influence pregnancy outcomes in a prospective study of Hutterite women [13] [14] [15] . Among the 189 eQTLs we identified, two were also associated with fecundability (time to pregnancy) [15] . The most significant association was rs2071473 (P = 1.3x10 -4 ), an eQTL associated with expression of TAP2 in the HLA class II region. The C allele of rs2071473 was associated with longer intervals to pregnancy and higher expression of TAP2 gene in mid-secretory phase (receptive) endometrium. The median time to pregnancy, for example, was 2.0, 3.1, and 4.0 months among women with the TT, CT, and CC genotypes, respectively [15] .
An essential step in implantation is the establishment of receptivity by the hormoneprimed endometrium. This 'window of implantation' occurs in the mid-secretory phase of the menstrual cycle [16] , after endometrial stromal fibroblasts (ESFs) have differentiated (decidualized) into decidual stromal cells (DSCs) in response to progesterone and cyclic-AMP (cAMP) [17, 18] . Decidualization underlies a suite of molecular, cellular, and physiological responses that support pregnancy including maternal immunotolerance of the fetal allograft [18, 19] . Although function of TAP2 in the decidualized endometrium and the process of implantation have not been elucidated, TAP2 plays an integral role in translocating peptides from the cytosol to MHC class I molecules in the endoplasmic reticulum [20] . These data suggest that TAP2-dependent antigen processing and presentation by DSCs plays a role in establishing receptivity to implantation and immunotolerance at the maternal-fetal interface, likely by modifying the interactions between DSCs and immune cells in the decidualized endometrium [21] .
Here we explore the functional significance and evolutionary history of the rs2071473 C/T polymorphism. We first replicate the association between rs2071473 genotype and TAP2 expression using GTEx data and demonstrate that TAP2 is expressed by DSCs at the maternalfetal interface. Next, we show that rs2071473 is located within a cAMP/progesterone responsive regulatory element and disrupts a putative DDIT3 (CHOP10) biding site that functions as a repressor with the rs2071473 T allele and an enhancer with the C allele. Remarkably, we found that the C/T polymorphism arose before the divergence of modern and archaic humans, is segregating at intermediate to high frequencies across human populations, and has genetic signatures of long-term balancing selection.
Methods rs2071473 is a multi-tissue eQTL for TAP2, HLA-DOB, and HLA-DRB6
We replicated the association between the T/C polymorphism at rs2071473 and TAP2 expression levels using GTEx Analysis Release V6 (dbGaP Accession phs000424.v6.p1) data for 35 tissues including the uterus [22, 23] . We also used GTEx data to identify other genes for which rs2071473 was an eQTL. Briefly, we queried the GTEx database using the 'Single tissue eQTLs search form' for SNP rs2071473 (http://www.gtexportal.org/home/eqtls/bySnp).
TAP2 is expressed by decidual stromal cells at the maternal-fetal interface
To determine the cell-type localization of TAP2 in the endometrium, we used data from the Human Protein Atlas immunohistochemistry collection (www.proteinatlas.org) [24] for endometrium, placenta, and decidua. We examined the expression of TAP2 in the endometrium across the menstrual cycle [25] , in mid-secretory phase endometrial biopsies from women not taking hormonal contraceptives (n=11), and women using either the progestin-based contraceptives depot medroxyprogesterone acetate (DMPA) or levonorgestrel intrauterine system (LNG-IUS) for at least 6 months [26] , and in DSCs treated with a PGR-specific siRNA or a non-targeted siRNA [27] using previously generated microarray expression data. These microarray datasets were analyzed with the GEO2R analysis package (http://www.ncbi.nlm.nih.gov/geo/geo2r/), which implements the GEOquery [28] and limma R packages [29, 30] from the Bioconductor project to quantify differential gene expression. We also examined TAP2 expression in RNA-Seq data previously generated from ESFs treated with control media or differentiated (decidualized) with cAMP/MPA into DSCs [31, 32] .
Cell culture and luciferase assays
Cell culture Endometrial stromal fibroblasts (ATCC CRL-4003) immortalized with telomerase were maintained in phenol red free DMEM (Gibco) supplemented with 10% charcoal stripped fetal bovine serum (CSFBS; Gibco), 1x ITS (Gibco), 1% sodium pyruvate (Gibco), and 1% Lglutamine (Gibco). Decidualization was induced using DMEM with phenol red (Gibco), 2% CSFBS (Gibco), 1% sodium pyruvate (Gibco), 0.5mM 8-Br-cAMP (Sigma), and 1µM medroxyprogesterone acetate (Sigma).
Plasmid Transfection and Luciferase Assays
A 1000bp region spanning 50bp upstream of rs2071732 to the 3'-end of the PGR ChIP- We inferred ancestral sequences of the 101bp region using the ancestral sequence reconstruction (ASR) module of the Datamonkey web-sever (http://www.datamonkey.org) [33] which implement joint, marginal, and sampled reconstruction methods [34] , the nucleotide alignment of the 101bp, the best fitting nucleotide substitution model (HKY85), a general discrete model of site-to-site rate variation with 3 rate classes, and the phylogeny shown in Fig   4A . All three ASR methods reconstructed the same sequence for the ancestral human sequence at 1.0 support.
rs2071473 has signatures of balancing in humans and diversifying selection in primates
To infer if there was evidence for positive selection acting on the derived T allele we used an improved version of the EvoNC method [35] that has been modified into a branch-site model [36, 37] , and implemented in HyPhy v2.22 [37, 38] . This method utilizes the MG94HKY85 nucleotide substitution model, which was also the best-fitting nucleotide substitution model for our target non-coding region and neutral rate proxy, and includes 10 replicate likelihood searches. Although this implementation of the EvoNC method that has been modified into a branch-site model capable of identifying positively selected sites in a priori defined lineages using Naive Empirical Bayes (NEB) and Bayes Empirical Bayes (BEB), previous studies have shown that these methods have high type-I and type-II error rates. Therefore, we inferred evidence for without reference to NEB or BEB identified sites and instead relied on a significant likelihood ratio test between the null and alternate models. We analyzed an alignment of the 101bp region described above, the phylogeny shown in Fig 4A, synonymous sites from the flanking HLA-DOB and TAP2 genes which were identified from the same primate species using the method described above.
Results

rs2071473 is a multi-tissue eQTL for TAP2, HLA-DOB, and HLA-DRB6
We previously have shown that a T/C polymorphism at rs2071473 is an eQTL for TAP2
in mid-secretory phase endometrium [15] . To replicate this observation in an independent cohort and in additional tissues, we tested if rs2071473 was correlated with TAP2 expression using GTEx data. Similarly to our previous observation, we found that rs2071473 was an eQTL for TAP2 in GTEx uterus samples (n=70, β=-1.1, P=9.1×10 -11 ; Fig 1A) as well as 34 other tissues ( Fig 1B) ; the largest effect size was observed in the uterus (Fig 1B) . We also used GTEx data to identify other genes for which rs2071473 was an eQTL and found that it was an eQTL for HLA-DOB in 25 tissues (β=-0.27 --0.91, P=5.4×10 -9 -9.1×10 -20 ; Supplementary Table 1 ) and
for HLA-DRB6 in four tissues (β=0.37 -0.46, P=6.7×10 -6 -2.1×10 -8 ; Supplementary Table 1 ).
However, rs2071473 was not identified as a uterine eQTL for HLA-DOB or HLA-DRB6 because neither gene is expressed in GTEx uterine tissues.
TAP2 is expressed by decidual stromal cells at the maternal-fetal interface
Although TAP2 is expressed in the uterus, the mid-secretory phase endometrium is a complex tissue composed of numerous cell-types including perivascular mesenchymal stem-like cells [19, 39] , which are the likely precursors of endometrial stromal fibroblasts (ESFs) [18] , decidual stromal cells (DSCs) [17, 18] , luminal and glandular epithelial cells, endothelial cells lining blood vessels, uterine natural killer cells (uNK) [40] , uterine macrophage (uMP) [41, 42] , multiple populations of T-cells [43] [44] [45] [46] , and dendritic cells [47, 48] , among many others. To determine which cell-types express TAP2 we examined its localization in endometrial biopsies from the Human Protein Atlas immunohistochemistry collection. We found that TAP2 staining was localized primarily to the luminal and glandular epithelium and ESFs in non-pregnant endometrium (Fig 2A) , was particularly intense in DSCs in pregnant endometrium (Fig 2B) , and was absent from trophoblast cells (Fig 2B/C) . Thus, TAP2 is expressed by maternal cells particularly DSCs at the maternal-fetal interface.
Next we tracked the expression of TAP2 in the endometrium across the menstrual cycle using previously generated microarray expression data [25] . We found that TAP2 expression reached its peak during the early secretory phase of the menstrual cycle and rapidly decreased in the mid-secretory phase (Fig 2D) , suggesting that down-regulation of TAP2 is regulated by progesterone and associated with endometrial receptivity to implantation. To infer if TAP2 expression in the endometrium is regulated by progesterone we took advantage of an existing gene expression dataset of mid-secretory phase endometrial biopsies from women not taking hormonal contraceptives (n=11), and women using either the progestin-based contraceptives depot medroxyprogesterone acetate (DMPA) or levonorgestrel intrauterine system (LNG-IUS)
for at least 6 months [26] . Consistent with regulation by progesterone, we found that TAP2
expression was significantly lower in the endometria of women taking DMPA (P=0.002) or LNG-IUS (P=0.012) compared to controls (Fig 2E) .
To directly test if TAP2 is regulated by progesterone, we examined its expression in RNA-Seq data from ESFs treated with control media or differentiated (decidualized) with cAMP/MPA into DSCs [31, 32] and found that TAP2 was down-regulated ~33% by cAMP/MPA treatment (Fig 2F) . To test if these effects were mediated by the progesterone receptor (PGR), we used a previously published dataset to compare TAP2 expression in DSCs treated with a PGR-specific siRNA or a non-targeted siRNA [27] and found that knockdown of PGR significantly up-regulated TAP2 expression in DSCs (P=0.01). Thus we conclude that TAP2 is down-regulated by progesterone during the differentiation of ESFs into DSCs and in the endometrium during the period of endometrial receptivity to implantation.
The rs2071473 variant switches a repressor into an activator
Our observations that rs2071473 is an eQTL for TAP2 and that TAP2 expression is down-regulated by progesterone suggests rs2071473 may be located within or linked to a progesterone responsive enhancer. To identify such a regulatory element we used previously ChIP-Seq data from DSCs for the transcription factors PGR [32, 49, 50] and NR2F2 (COUP-TFII) [51] , which regulate the transcriptional response to progesterone and immune genes, respectively, H3K27ac which marks active enhancers, H3K4me3 which marks active promoters [32] , and DNaseI-Seq and FAIRE-Seq to identify regions of open chromatin [32] . We found that rs2071473 was located 260bp upstream of PGR and NR2F2 binding sites, within local DNase FAIRE peaks, and in a region of elevated H3K4me3 and H3K27ac signal (Fig 3A) suggesting this region is a progesterone responsive cis-regulatory element.
To test if this locus has regulatory potential we synthesized a 1000bp region spanning 50bp upstream of rs2071732 to the 3'-end of the PGR ChIP-Seq peak (Fig 3A) with either the reference C allele or the alternate T allele and cloned them into the pGL3-Basic luciferase reporter vector, which lacks both an endogenous promoter and enhancer. Next we transiently transfected either the pGL3Basic-rs2071732T or pGL3Basic-rs2071732C luciferase reporter along with the pRL-null internal control vector into ESFs and DSCs and quantified luciferase and renilla expression using a dual luciferase assay.
We found that luciferase expression was significantly lower in ESFs (Wilcox test P=1.75×10 -11 ) and DSCs (Wilcox test P=2.87×10 -9 ) transfected with the pGL3Basic-rs2071732T
reporter compared to empty pGL3Basic vector controls (Fig 3B) 3B) .
Thus we conclude that the locus in which rs2071473 resides is a progesterone responsive cisregulatory element and that the T/C polymorphism switches an enhancer into a repressor.
The rs2071473 C allele likely disrupts a DDIT3 binding site
The T/C polymorphism at rs2071473 is several hundred base pairs away from the PGR and NR2F2 binding sites and is therefore unlikely to directly effect their binding (Fig 3A) .
However our luciferase assay results indicate that the T/C polymorphism has regulatory effects, suggesting this polymorphism disrupts a binding site for a transcriptional repressor or creates a binding site transcriptional activator. To infer which of these scenarios was most likely we identified putative transcription factor binding sites in a 25bp window upstream and downstream of rs2071473 using ConSite [52] and JASPAR transcription factor binding site profiles [53] . We found that the T/C polymorphism occurs at an invariant T site in the DDIT3 motif (TGCAAT), which was predicted to abolish DDIT3 binding (Fig 3A, inset) . Similarly, the T/C polymorphism was predicted by DeepSea [54] , a deep learning-based algorithm that infers the effects of single nucleotide substitutions on chromatin features such as transcription factors binding, DNase I sensitivitity, and histone marks, to generally have a negative effects on regulatory functions across multiple cell-types (Fig 3C) .
While DDIT3 (also known as CHOP10 and GADD153) was initially characterized as a dominant negative inhibitor of CEBP family transcription factors [55] , it can also function as a transcription factor [56, 57] and is transcriptionally regulated the cAMP [58] . Indeed we found that CHOP10 expression was down-regulated by cAMP/MPA in our RNA-Seq data from ESFs but had no effect on luciferase expression from the the pGL3Basic-rs2071732C reporter in either ESFs or DSCs (P> 0.21; Fig 3B) .
To test if this regulatory element is progesterone-responsive, we co-transfected ESFs and DSCs with a PGR rather than a DDIT3 expression vector and repeated the luciferase assays described above. Expression of PGR did not affect luciferase expression from the pGL3Basic-rs2071732T reporter in ESFs (Wilcox test P=0.67) but did enhance repression in DSCs (Wilcox test P=9.56×10 -5 ; Fig 3B) . Fig 3B) . These data suggest that the reference C allele likely disrupts a DDIT3 biding site, which unmasks a progesterone responsive enhancer.
The rs2071473 C allele is derived in humans and has evidence of positive selection
To reconstruct the evolutionary history of the T/C polymorphism we identified a region spanning 50bp upstream and downstream of rs2071473 from 45 primates, including species from each the major primate lineages, multiple sub-species of African apes (Homininae), as well as modern and archaic (Altai Neanderthal and Denisova) humans. Next we used maximum likelihood methods to reconstruct ancestral sequences for this 101bp region. We found that the T allele was ancestral in primates and that the C variant was only found in modern human populations as well as the Altai Neaderthal genome (Fig 4A) . Next we examined the frequency of these alleles across the Human Genome Diversity Project (HGDP) populations as well as two aboriginal Australians and found that the derived and ancestral alleles were segregating at intermediate to high frequencies in nearly all human populations (Fig 4B) . These results indicate that the derived C variant at rs2071473 arose before the divergence of modern and archaic human lineages.
To test if the derived C allele may have been positively selected we used a branch-sites version of the EvoNC method [35] [36] [37] . In this analysis, the nucleotide substitution rate in and Pi (86.41-107.71) (Fig 5) .
To test if in the rs2071473 enhancer region evolve under positive diversifying selection across primates we used the sites version of the EvoNC method [35] [36] [37] . We fit three models to the alignment described above: 1) A null model that constrains ζ ≤ 1 across all sites; 2) An alternate model that allows for categories of sites with ζ ≥ 1 and ζ < 1; and 3) An alternate model that allows for categories of sites with ζ < 1, ζ = 1, or ζ > 1. We found that the null model was not rejected in favor of alternate model 1 (LRT=0; P=1) , however, alternative model 2 was a better fit to the data than either the null model LRT=11.76; P=0.019) or alternative model 1 (LRT=11.78; P=0.0005). These data indicate that including distinct rate classes for sites with ζ < 1 or ζ = 1 significantly improves the alternate model, and suggest that positive diversifying selection acts on sites in this regulatory element across primates.
Discussion
The mechanisms that promote maternal tolerance of the antigentically distinct fetus are complex [64] and have been the subject of intense study since Medawar formulated the immunological paradox posed by pregnancy and proposed tolerance was achieved by physical separation of maternal and fetal tissues, maternal immunosuppression, and immaturity of fetal antigens [65] . It is now clear that rather than being a site of maternal immunosuppression [66] , the maternal immune system in the endometrium plays an active role in establishing a permissive environment for implantation, placentation, and gestation. For example, maternal regulatory T cells (Tregs) [44, 67] , shifts in the Th1/Th2/Th17 balance [45] , uterine natural killer cells [40, 68] , uterine dendritic cells [47] , uterine macrophage [69] , and signaling by DSCs [70] [71] [72] all contribute to establishing immunotolerance and even promote placental invasion into maternal tissues.
It has also become clear that the major histocompatibility complex (MHC) genes, which play an important role in the rejection of non-self tissues, contribute to maternal tolerance of the fetus [21] . Matching of HLA antigens between couples, for example, is associated with longer intervals from marriage to birth compared to couples not matching for HLA [73, 74] ; these longer intervals result from both higher miscarriage rates among couples matching for class I HLA-B
antigens [14] and longer intervals to pregnancy among couples matching for class II HLA-DR antigens [13] . Similarly, the non-classical HLA class I genes HLA-F are associated with fecundability whereas overwhelming evidence indicates maternal and fetal HLA-G genotypes are associated with miscarriage, recurrent pregnancy loss, and preeclampsia [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] .
Collectively these data implicate antigen presentation by MHC as one of the molecular mechanisms that underlie successful implantation, maternal immunotolerance, and the establishment and maintenance of pregnancy.
The ATP-binding cassette transporter TAP, a heterodimer composed of TAP1 and TAP2, translocates peptides from the cytosol to awaiting MHC class I molecules in the endoplasmic reticulum, which results in cell surface presentation of the trimeric MHC complex to immune cells such as T lymphocytes and natural killer cells [20] . Loss and reduced TAP expression leads to loss and reduced surface HLA expression [87] [88] [89] , altered surface HLA repertoires [90] , and the surface expression of distinct antigenic peptides that are recognized by cytotoxic T lymphocytes [91] . Our observation that TAP2 is highly expressed by DSCs at the maternal-fetal interface and that TAP2 expression levels are associated with fecundability suggests that changes in TAP2 stoichiometry may alter MHC processing and thus interactions between DSCs and maternal immune cells. Indeed DSCs express numerous HLA class I molecules, including HLA-G and HLA-F [92, 93] , which are transcriptionally up-regulated by progesterone during decidualization [72] .
While the connection between TAP2 expression levels in DSCs and immune signaling are obvious, our observation that the ancestral and derived alleles of rs2071473 arose before the divergence of modern and archaic humans and has signatures of long-term balancing selection is unexpected. The HLA region has long been recognized to be under balancing selection [59, 60, 63, 94, 95] . These signals, however, are usually attributed to polymorphisms within the classical HLA class I genes rather regulatory regions (cf. [96] ). TAP2 and rs2071473
are also located near the distal end of the HLA region and bounded by regions of high recombination, including a recombination hotspot within TAP2 [97] , and in a LD block that includes few other HLA genes. These data suggest that the signal of balancing selection at rs2071473 is distinct from other signals of balancing selection in the HLA region, but it is difficult to disentangle these signals given the relatively strong linkage across the HLA region. Thus it is possible that the C/T polymorphism at rs2071473 is not itself under balancing selection and is linked to the balanced site.
If the target of balancing selection is rs2071473, what selective forces are acting to maintain the ancestral and derived alleles? Balancing selection is generally attributed to heterozygote advantage (overdominance), frequency dependent selection, or antagonistic pleiotropy [98] , which are all probable evolutionary scenarios to explain maintenance of the ancestral and derived alleles of rs2071473. Intriguingly, GWA studies have found rs2071473 genotype is associated with ulcerative colitis [99] , Crohn's disease [100] , and sarcoidosis [101, 102] in addition to fecundability. For example, the ancestral T allele is significantly associated with ulcerative colitis [99] and shorter time to pregnancy whereas the derived C allele is significantly associated with Crohn's disease [100] and longer time to pregnancy suggesting theses alleles may be maintained antagonistic pleiotropy.
Methods rs2071473 is a multi-tissue eQTL for TAP2, HLA-DOB, and HLA-DRB6
TAP2 is expressed by decidual stromal cells at the maternal-fetal interface
To determine the cell-type localization of TAP2 in the endometrium, we used data from the Human Protein Atlas immunohistochemistry collection (www.proteinatlas.org) [24] for endometrium, placenta, and decidua. We examined the expression of TAP2 in the endometrium across the menstrual cycle [25] , in mid-secretory phase endometrial biopsies from women not taking hormonal contraceptives (n=11), and women using either the progestin-based contraceptives depot medroxyprogesterone acetate (DMPA) or levonorgestrel intrauterine system (LNG-IUS) for at least 6 months [26] , and in DSCs treated with a PGR-specific siRNA or a non-targeted siRNA [27] using previously generated microarray expression data. These microarray datasets were analyzed with the GEO2R analysis package (http://www.ncbi.nlm.nih.gov/geo/geo2r/), which implements the GEOquery [28] and limma R packages [29, 30] from the Bioconductor project to quantify differential gene expression. We also examined TAP2 expression in RNA-Seq data previously generated from ESFs treated with control media or differentiated (decidualized) with cAMP/MPA into DSCs [31, 32] . We inferred ancestral sequences of the 101bp region using the ancestral sequence reconstruction (ASR) module of the Datamonkey web-sever (http://www.datamonkey.org) [33] which implement joint, marginal, and sampled reconstruction methods [34] , the nucleotide alignment of the 101bp, the best fitting nucleotide substitution model (HKY85), a general discrete model of site-to-site rate variation with 3 rate classes, and the phylogeny shown in Fig   4A. All three ASR methods reconstructed the same sequence for the ancestral human sequence at 1.0 support.
Cell culture and luciferase assays
rs2071473 has signatures of balancing in humans and diversifying selection in primates
To infer if there was evidence for positive selection acting on the derived T allele we used an improved version of the EvoNC method [35] that has been modified into a branch-site model [36, 37] , and implemented in HyPhy v2.22 [37, 38] . This method utilizes the MG94HKY85 nucleotide substitution model, which was also the best-fitting nucleotide substitution model for our target non-coding region and neutral rate proxy, and includes 10 replicate likelihood searches. Although this implementation of the EvoNC method that has been modified into a branch-site model capable of identifying positively selected sites in a priori defined lineages using Naive Empirical Bayes (NEB) and Bayes Empirical Bayes (BEB), previous studies have shown that these methods have high type-I and type-II error rates. Therefore, we inferred evidence for without reference to NEB or BEB identified sites and instead relied on a significant likelihood ratio test between the null and alternate models. We analyzed an alignment of the 101bp region described above, the phylogeny shown in Fig 4A, synonymous sites from the flanking HLA-DOB and TAP2 genes which were identified from the same primate species using the method described above. F st , Tajima's D, and Fay and Wu's H data for CEU and YRI populations were obtained from the 1000 Genomes Selection Browser 1.0 [103] . 
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